- Drugs List
- Therapeutic Indications
- Precautions and Warnings
- Pregnancy and Lactation
- Side Effects
Parenteral formulations of cidofovir.
Treatment of cytomegalovirus (CMV) retinitis in patients with AIDS
Cytomegalovirus retinitis in adults with acquired immunodeficiency syndrome (AIDS) and without renal dysfunction.
Induction treatment: 5mg per kg once a week, for two weeks.
Maintenance treatment: 5mg per kg every two weeks.
For intravenous infusion only. Must be diluted in 100ml normal saline prior to administration.
Children under 18 years
Concomitant medication consider washout period, see prescribing information
Proteinuria above 99 mg/dl
Renal impairment - creatinine clearance below 56 ml/minute
Precautions and Warnings
Females of childbearing potential
Patients over 60 years
Treatment does not prevent risk of transmission of HIV
Advise ability to drive/operate machinery may be affected by side effects
Anti-emetics may be required during therapy
Concurrent probenecid is required to minimise potential nephrotoxicity
Discontinue potentially nephrotoxic drugs at least 7 days before starting
Patients must receive 1L of normal saline intravenously prior to each dose
Treatment should be initiated by doctor experienced in HIV management
Avoid contact of powder with skin and mucous membranes
Avoid contact of prepared solution with skin and mucous membranes
Staff: Not to be handled by pregnant staff
Use only if the solution is clear and colourless
Monitor serum creatinine levels and urine protein levels before each dose
Monitor ophthalmic function
Perform differential white blood cell count before each dose
Consider discontinuation if uveitis/iritis occurs
Suspend and rehydrate if serum creatinine increases by 44micromol/L or more
Discontinue if renal function deteriorates
Suspend therapy and rehydrate if proteinuria is equal to or more than 2+
Male: May cause infertility
Female: Contraception required during and for 1 month after treatment
Male: Use barrier contraception during and for 3 months after treatment
Pregnancy and Lactation
Cidofovir is contraindicated during pregnancy.
The manufacturer does not recommend using cidofovir during pregnancy.
At the time of writing there is limited data regarding the use of cidofovir during pregnancy. Studies in animals have shown some reproductive toxicity. It is not known if cidofovir crosses the placenta, but its low molecular weight suggests a risk of passage to the foetus.
Cidofovir is contraindicated during breastfeeding.
The manufacturer recommends discontinuing breastfeeding whilst taking cidofovir.
There is limited data on the use of cidofovir during breastfeeding. It is not known if cidofovir or its metabolites are excreted in breast milk. Effects on exposed infants are unknown.
Acute renal failure
Pain - generalised
Serum creatinine increased
It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.
The following number will direct the caller to the relevant local centre (0844) 892 0111
Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).
Last Full Review Date: January 2020
Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 10th edition (2015) ed. Briggs, G., Freeman, R. Wolters Kluwer Health, Philadelphia.
Summary of Product Characteristics: Cidofovir Tillomed 75mg/ml concentrate for solution for infusion. Tillomed Laboratories Ltd. Revised October 2017.
Already a member? Log in
Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content
FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.